The Netherlands just drew a bigger fence around its technology sector. The Dutch government announced an expansion of its foreign investment screening regime to cover six additional categories of sensitive technology, including artificial intelligence and biotechnology.

The move extends the reach of the Vifo Act, the country’s first comprehensive framework for reviewing foreign investments. Originally enacted in 2023, the law initially targeted sectors like semiconductors and quantum computing.

What’s actually changing

The six newly designated sensitive technologies include artificial intelligence, biotechnology, advanced materials and nanotechnology, sensor and navigation technology, and nuclear technology for medical use. Each of these categories will now trigger screening requirements when foreign entities attempt to acquire control over Dutch companies operating in those spaces.

The formal proposal to expand the guidelines was first introduced between December 19 and 20, 2024. Implementation had been expected in the second half of 2025 or early 2026, and the government’s announcement on June 8, 2026, marks the culmination of that timeline.

The original Vifo Act became effective on June 1, 2023. Under the expanded rules, investments that could provide non-Dutch entities with control over Dutch companies in these sectors will face heightened scrutiny.

The global context

The Netherlands isn’t operating in a vacuum here. The EU introduced its FDI screening regulation back in 2020, encouraging member states to build national mechanisms. The UK passed its National Security and Investment Act in 2022.

The Netherlands had a specific catalyst that made its semiconductor controls particularly urgent. The country is home to ASML, arguably the most critical company in the global chip supply chain. When the Dutch government restricted exports of advanced lithography equipment, it was already signaling that protecting technological sovereignty was a top priority.

What this means for investors

Mergers and acquisitions involving Dutch AI and biotech firms will now require regulatory review before foreign acquirers can close deals. Venture capital and private equity firms with foreign limited partners may also need to evaluate whether their fund structures trigger screening obligations, depending on the ultimate beneficial ownership.

For the crypto and digital assets sector specifically, there is no direct overlap with this particular expansion. The Vifo Act’s new categories are focused on physical and applied sciences, not financial technology or blockchain infrastructure.